Sep 2018 $8 M No. 5 $2 to $10 million 31
Axion BioSystems, Inc.: Raise no. 5, Sep 2018 × Investors in this round 31 investors had bought by the notice of Oct 5, 2018: 31 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $5 million to $25 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James J. Ross · Executive Officer, Director · Chief Technical Officer Thomas J. O'Brien · Executive Officer, Director · President and Chief Executive Officer David J. Gibson · Director Glenn J. Epstein · Director Jay J. Teich · Director Michelle J. Jarrard · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas O'Brien, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 5, 2018. Read the notice at the SEC .
equity SEC May 2016 $6 M No. 4 $2 to $10 million 16
Axion BioSystems, Inc.: Raise no. 4, May 2016 × Investors in this round 16 investors had bought by the notice of May 17, 2016: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $5 million to $25 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James J. Ross · Executive Officer, Director · Director, President and Chief Technical Officer Thomas J. O'Brien · Executive Officer, Director · Director, Chief Executive Officer David J. Gibson · Director Glenn J. Epstein · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas O'Brien, President and chief executive officer. Source: SEC Form D, newest notice filed May 17, 2016. Read the notice at the SEC .
equity, options SEC Apr 2012 $3 M No. 3 $2 to $10 million 17
Axion BioSystems, Inc.: Raise no. 3, Apr 2012 × Investors in this round 17 investors had bought by the notice of May 9, 2012: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James J. Ross · Executive Officer, Director · Director and Vice President Julian A. Bragg · Executive Officer · Vice President Stephen J. DeWeerth · Executive Officer · Vice President Swaminathan J. Rajaraman · Executive Officer · Vice President Thomas J. O'Brien · Executive Officer, Director · Director, President and Chief Executive Officer Glenn A. Epstein · Director Mark J. Allen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas O'Brien, President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 9, 2012. Read the notice at the SEC .
equity, options SEC Jul 2010 $2 M No. 2 $2 to $10 million 10
Axion BioSystems, Inc.: Raise no. 2, Jul 2010 × Investors in this round 10 investors had bought by the notice of Jul 28, 2010: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Edgar J. Brown · Executive Officer · Vice President James J. Ross · Executive Officer, Director · Director and Vice President Julian A. Bragg · Executive Officer · Vice President Stephen J. DeWeerth · Executive Officer · Vice President Swaminathan J. Rajaraman · Executive Officer · Vice President Thomas J. O'Brien · Executive Officer, Director · Director, President and Chief Executive Officer Glenn A. Epstein · Director Mark J. Allen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas O'Brien, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 28, 2010. Read the notice at the SEC .
equity, options SEC Apr 2009 $1 M No. 1 Under $2 million 19
Axion BioSystems, Inc.: Raise no. 1, Apr 2009 × Investors in this round 19 investors had bought by the notice of Apr 30, 2009: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in De People named in the notice Edgar Brown · Executive Officer · Vice President James Ross · Executive Officer, Director · Director and Vice President Julian A. Bragg · Executive Officer · Vice President Stephen DeWeerth · Executive Officer · Vice President Swaminathan Rajaraman · Executive Officer · Vice President Thomas J. O'Brien · Executive Officer, Director · Director, President and Chief Executive Officer Greg Dane · Director Mark Allen · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas J. O'Brien, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 30, 2009. Read the notice at the SEC .
equity, options SEC